Medexus Pharmaceuticals Inc. (MEDXF)

Medexus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	23.97	5.26	13.07	10.02	18.7
Cash & Short-Term Investments	23.97	5.26	13.07	10.02	18.7
Cash Growth	356.19%	-59.79%	30.45%	-46.44%	257.42%
Accounts Receivable	13.17	23.87	21.97	13.39	18.4
Other Receivables	0.14	0.16	0.41	1.02	0.43
Receivables	13.31	24.03	22.38	14.41	18.83
Inventory	39.82	36.72	22.85	21.35	14.67
Prepaid Expenses	3.1	4.19	12.38	2.06	4.71
Other Current Assets	0.38	2.3	2.3	1.28	1.67
Total Current Assets	80.57	72.5	72.97	49.11	58.57
Property, Plant & Equipment	0.69	0.78	0.9	1.22	0.8
Goodwill	10	10.28	10.28	10.69	10.65
Other Intangible Assets	71.6	64.14	70.37	76.57	76.36
Long-Term Deferred Tax Assets	8.98	8.04	6.81	-	-
Other Long-Term Assets	-	-	-	1.64	2.13
Total Assets	171.84	155.73	161.33	139.23	148.51
Accounts Payable	5.73	7.75	10.16	12.05	14.86
Accrued Expenses	35.29	35.48	23.26	17.13	12.47
Current Portion of Long-Term Debt	36.79	15.74	42.71	15.05	10.57
Current Portion of Leases	0.19	-	-	-	-
Current Income Taxes Payable	1.37	1.32	1.18	0.03	0.51
Other Current Liabilities	17.94	5.94	6.19	3.86	1.53
Total Current Liabilities	97.31	66.23	83.5	48.11	39.94
Long-Term Debt	-	33.61	26.78	39.03	34.09
Long-Term Leases	0.2	0.54	0.6	0.78	0.21
Long-Term Deferred Tax Liabilities	-	-	-	1.52	2.65
Other Long-Term Liabilities	22.19	25.03	28.01	31.99	53.61
Total Liabilities	119.7	125.41	138.88	121.43	130.5
Common Stock	96.1	76.39	69.01	68.69	66.69
Additional Paid-In Capital	12.01	12.01	11.31	10.38	9.5
Retained Earnings	-62	-64.24	-64.03	-65.25	-62.37
Comprehensive Income & Other	6.03	6.17	6.16	3.97	4.2
Shareholders' Equity	52.14	30.32	22.45	17.79	18.02
Total Liabilities & Equity	171.84	155.73	161.33	139.23	148.51
Total Debt	37.18	49.9	70.08	54.86	44.87
Net Cash (Debt)	-13.21	-44.64	-57.01	-44.84	-26.17
Net Cash Per Share	-0.50	-2.00	-2.78	-2.26	-1.72
Filing Date Shares Outstanding	32.26	24.46	20.25	19.95	19.17
Total Common Shares Outstanding	32.26	24.46	20.18	19.95	19.17
Working Capital	-16.74	6.27	-10.53	1	18.63
Book Value Per Share	1.62	1.24	1.11	0.89	0.94
Tangible Book Value	-29.46	-44.09	-58.21	-69.46	-69
Tangible Book Value Per Share	-0.91	-1.80	-2.88	-3.48	-3.60
Machinery	1.26	1.12	1.07	1.06	0.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.